Vikram Juneja

Vikram Juneja is a distinguished professional in the field of cancer immunology with extensive experience in various leadership roles within prominent organizations. Currently serving as Senior Director at BioNTech SE since July 2020, Juneja previously held multiple positions at Neon Therapeutics from November 2016 to June 2020, including Associate Director and Group Leader in Cancer Immunology. Earlier, from February 2012 to November 2016, Juneja was a Graduate Student at Harvard Medical School, focusing on the PD-1 pathway in the tumor microenvironment and utilizing advanced methodologies such as flow cytometry and RNAseq. Juneja holds a PhD in Biomedical/Medical Engineering from the Massachusetts Institute of Technology, an MPhil in Genetics from the University of Cambridge, and a BS in Mechanical Engineering from UC San Diego.